Cardiovascular Hub
Featured this Month
Explore resources tailored to support your everyday practice.
Clinical Audit: Heart Failure Management for Primary Care
Assess how your prescribing aligns with care in this CPD-accredited audit of GDMT use in heart failure. Sponsored by AstraZeneca.
2026 Consensus Statement
This Australian consensus focuses on GDMT in-hospital for acute Heart Failure (HFrEF and HFpEF).
Clinical Audit: Heart Failure Management for Specialists
An 8-hour CPD-accredited program tailored for specialists in secondary care. This program helps assess and optimise use of guideline-directed medical therapy, including ACEIs/ARNIs, beta blockers, MRAs, and SGLT2i.
Sponsored by AstraZeneca.
Patient Video: Living with Heart Failure
A short video sharing a personal journey with heartfailure, designed to support patient conversations.
Healthcare Professional Resources
Explore resources tailored to support your everyday practice.
CV Management Guidelines
Heart Failure Management: Key Updates
Learn why rapid sequencing and the “four pillars” approach are transforming care for patients with HFrEF and HFpEF.
2024 ESC Hypertension Guidelines
Simplified blood pressure thresholds and treatment strategies for better outcomes.
ESC Guidelines - Biomarkers in HF
Discover how biomarkers can guide heart failure treatment in this expert video featuring Dr. Hani Sabbour.
Heart Failure Management: Key Updates
An international modified Delphi consensus study captures expert perspectives on the diagnosis and management of HFpEF.
Consensus statement of Australian clinicians for the pharmacological management of heart failure
GDMT Implementation in Clinical Practice
Explore resources tailored to support your everyday practice.
Real World Evidence
Explore how Advara HeartCare’s Cardiology Group is transforming HFrEF treatment with real-world implementation of four-pillar therapy and SGLT2 inhibitors.
Inside the HFrEF Guideline Initiative
Highlights from Advara HeartCare’s nurse-led program, shared at CSANZ 2024, with reflections from Dr Leighton Kearney, A/Prof. David Eccleston and Racheal Watt.
Clinical Audit: Heart Failure Management for Nurses
An 8-hour CPD-accredited program for nurses focused on optimising use of ACEIs/ARNIs, beta blockers, MRAs, and SGLT2i in heart failure management.
Sponsored by AstraZeneca.
ESC-HF 2025 Highlights
Catch up on the latest data from ESC-HF 2025, including GDMT implementation, NT-proBNP as a screening strategy, and the impact of dapagliflozin on quality of life.
National HFpEF Program
A nurse-led, cardiologist-supported initiative by Advara HeartCare, this program reviewed patients against GDMT, providing real-world evidence and insights presented at CSANZ 2025.
iHALO Project
A local initiative in Hunter New England LHD, the iHALO Project focused on improving HFrEF management through enhanced prescribing at discharge and rapid access clinics, presented at CSANZ 2025.
Heart Failure Patient Identification, Screening & Diagnosis
DETECT Tools for Heart Failure
Access practical tools to support the identification and recall of patients with heart failure.
Understanding HFpEF vs HFrEF
Explore the crucial differences between the two common types of Heart Failure: HFpEF (Heart Failure with Preserved Ejection Fraction) and HFrEF (Heart Failure with Reduced Ejection Fraction).
Spotlight on Heart Failure: The Impact of Early Detection
Dr Javed Butler discusses his perspective on the factors that interfere with the early detection of heart failure and how to address these factors when assessing your patients.
Spotlight on Heart Failure: The Impact of Treatment Delay
Dr Javed Butler highlights the impact of treatment delay on patients with heart failure and how acting earlier can have positive outcomes on patient functioning.
Role of Primary Care in Heart Failure
SGLT-2i and HFrEF
Prof Sindone speaks about the role of the GP in optimising to GDMT with an SGLT-2i, regardless of T2D status.
Importance of Early Referral in HF by Primary Care
General Practitioner Dr Naresh Kanumilli discusses the importance of early referral for patients with heart failure early and the role primary care plays in this process.
Evidence for Dapagliflozin in Heart Failure
DAPA-HF + DELIVER Data
Hear from Prof. Andrew Sindone as he unpacks the pooled analysis of DAPA-HF and DELIVER trials. Gain key insights into dapagliflozin’s role in heart failure across all LVEF ranges.
Treating Patients with Heart Failure with Prof. Zaheer Yousef
Prof. Zaheer Yousef shares a quick (~1 min) commentary on treating patients with reduced and preserved ejection fraction with results from the DAPA-HF and DELIVER trials.
Research Review: DAPA-HF and DELIVER Study Review
Quick look at the combined trial data exploring dapagliflozin use across the entire ejection fraction range in heart failure care.
DAPA-HF Clinical Trial Summary
A concise overview of the DAPA HF study design, patient profile, primary endpoints, and the CKD related PBS listing details for dapagliflozin.
DELIVER Clinical Trial Summary
A brief snapshot of the DELIVER trial’s design and key endpoints in HF with mildly reduced/preserved EF, plus the most recent PBS listing context for dapagliflozin.
Patient Resources
Access helpful resources to share with your patients.
You might also be interested in
Abbreviations: HF, heart failure; GDMT, guidelines-directed medical therapy.
Want to know more?
If you have any questions or would like to be kept updated on new training
resources please subscribe to our email newsletter or reach out below.
GPCE 24th - 26th May 2024, ICC Sydney
Join us at GPCE Sydney’s Education Session, Heart Failure with preserved ejection fraction (HFpEF): Should this be managed in primary care?
Spotlight on Heart Failure Management: When should comprehensive therapies be initiated?
Dr. Javed Butler outlines his approach to ensure optimal initiation of comprehensive therapy for heart failure management.
Spotlight on Heart Failure with Reduced Ejection Fraction: Cardiologists’ Perspective
Dr Javed Butler gives his perspective on “stable” heart failure and the risk factors to be aware of when assessing patients.
Spotlight on Heart Failure: A Cardiologist's Perspective
Professor Mark Petrie in this video answers the question: Is there such a thing as “stable heart failure patients”?
Early treatment for Chronic Heart Failure patients
General Practitioner Dr Gary Deed discusses the importance of treating patients with heart failure early and the role primary care plays in this process.